Indefinite Delivery Contract SPE2DB20D1109

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. It has an ultimate completion date of November 30, 2026.

The IDC is further supported by numerous delivery order awards to AmerisourceBergen for specific pharmaceutical and medical products. These orders, valued up to millions of dollars each, cover a wide variety of essential healthcare items such as Humira, Trulicity, Ozempic, Nurtec ODT, Topiramate ER, Skyrizi, and more. The contracts do not have any set-aside designations, indicating open competition. AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities, demonstrating the company's extensive role in supplying critical healthcare products to various federal government agencies and military treatment facilities.